FysioDanmark Helsinge DCJ ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  6.2% 19.5% 19.4% 2.5% 10.9%  
Credit score (0-100)  39 6 6 62 21  
Credit rating  BBB B B BBB BB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 -0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  -11.5 -23.6 -8.1 -6.3 -7.5  
EBITDA  -11.5 -23.6 -8.1 -6.3 -7.5  
EBIT  -11.5 -23.6 -8.1 -6.3 -7.5  
Pre-tax profit (PTP)  -178.3 -915.1 -8.1 317.6 -336.4  
Net earnings  -175.2 -810.6 -6.4 316.5 -323.8  
Pre-tax profit without non-rec. items  -178 -915 -8.1 318 -336  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  905 94.1 87.7 404 -107  
Interest-bearing liabilities  0.0 0.0 0.0 -0.0 118  
Balance sheet total (assets)  945 104 97.7 414 1,712  

Net Debt  0.0 -14.2 0.0 -9.7 118  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  -11.5 -23.6 -8.1 -6.3 -7.5  
Gross profit growth  -22.7% -105.2% 65.6% 23.1% -20.0%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  945 104 98 414 1,712  
Balance sheet change%  -49.8% -89.0% -6.1% 323.8% 313.2%  
Added value  -11.5 -23.6 -8.1 -6.3 -7.5  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -3.0 -4.0 -5.0 -5.0 -5.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  100.0% 100.0% 100.0% 100.0% 100.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -12.6% -174.3% -8.1% 124.2% -29.7%  
ROI %  -12.9% -183.1% -8.9% 129.2% -126.9%  
ROE %  -12.7% -162.3% -7.0% 128.7% -30.6%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  95.8% 90.4% 89.8% 97.6% -5.9%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 60.2% 0.0% 155.6% -1,579.9%  
Gearing %  0.0% 0.0% 0.0% -0.0% -111.2%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% -59,400.0% 7.9%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  1.4 10.4 9.8 9.0 0.9  
Current Ratio  1.4 10.4 9.8 9.0 0.9  
Cash and cash equivalent  0.0 14.2 0.0 9.7 0.0  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  14.1 94.1 87.7 80.1 -106.6  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0